Kabra Drugs

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue0.000.000.000.647.17
Expenses0.550.400.540.257.67
EBITDA-0.55-0.40-0.540.40-0.50
EBIT-0.55-0.40-0.540.39-0.50
Profit Before Tax-0.55-0.40-0.540.39-0.50
Net Profit-0.55-0.40-0.540.39-0.50
Financial Ratios
Operating Profit Margin0.00%0.00%0.00%0.00%-6.99%
Net Profit Margin0.00%0.00%0.00%0.00%-6.99%
Earning Per Share (Diluted)-1.24-0.39-0.530.21-0.21
Dividends Per Share0.000.000.000.000.00